Itau Unibanco Holding S.A.’s Enanta Pharmaceuticals ENTA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,016	Closed	-$87K	–	618
2018 Q3	$87K	Buy	+1,016	New	+$102K	0.01%	504
2017 Q1	–	Sell	-110	Closed	-$4K	–	740
2016 Q4	$4K	Sell	110 -230	-68%	-$6.59K	﹤0.01%	393
2016 Q3	$9K	Buy	+340	New	+$7.9K	﹤0.01%	313

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ENTA Position: Q4 2018 in Review

Itau Unibanco Holding S.A. sold out of Enanta Pharmaceuticals (ENTA) in Q4 2018, closing a stake of 1,016 shares — an estimated $87K sold.

Itau Unibanco Holding S.A. first reported a position in ENTA in Q3 2016 and held it in 3 quarters. The position peaked at $87K in Q3 2018. 183 funds tracked by Wall St. Rank hold ENTA as of Q4 2018.

Itau Unibanco Holding S.A. reported no remaining Enanta Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 1,016 Enanta Pharmaceuticals shares in Q4 2018, an estimated $87K.
Itau Unibanco Holding S.A. first reported a position in Enanta Pharmaceuticals in Q3 2016 and held it in 3 quarters.
Itau Unibanco Holding S.A.'s Enanta Pharmaceuticals position peaked at $87K in Q3 2018.
183 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2018.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2018, filed 13 Feb 2019.